nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Etoposide—muscle cancer	0.646	1	CbGbCtD
Raltegravir—CCR1—tendon—muscle cancer	0.00126	0.234	CbGeAlD
Raltegravir—CCR1—bone marrow—muscle cancer	0.00122	0.226	CbGeAlD
Raltegravir—CCR1—vagina—muscle cancer	0.00117	0.217	CbGeAlD
Raltegravir—CCR1—head—muscle cancer	0.00108	0.2	CbGeAlD
Raltegravir—Decreased appetite—Dactinomycin—muscle cancer	0.000888	0.00255	CcSEcCtD
Raltegravir—Dysgeusia—Etoposide—muscle cancer	0.000887	0.00254	CcSEcCtD
Raltegravir—Hyperhidrosis—Vincristine—muscle cancer	0.000882	0.00253	CcSEcCtD
Raltegravir—Fatigue—Dactinomycin—muscle cancer	0.00088	0.00253	CcSEcCtD
Raltegravir—Back pain—Etoposide—muscle cancer	0.000876	0.00251	CcSEcCtD
Raltegravir—Pain—Dactinomycin—muscle cancer	0.000873	0.0025	CcSEcCtD
Raltegravir—Hepatic failure—Doxorubicin—muscle cancer	0.000868	0.00249	CcSEcCtD
Raltegravir—Mood swings—Methotrexate—muscle cancer	0.000853	0.00245	CcSEcCtD
Raltegravir—Feeling abnormal—Dactinomycin—muscle cancer	0.000842	0.00241	CcSEcCtD
Raltegravir—Ill-defined disorder—Etoposide—muscle cancer	0.00084	0.00241	CcSEcCtD
Raltegravir—Anaemia—Etoposide—muscle cancer	0.000837	0.0024	CcSEcCtD
Raltegravir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000835	0.0024	CcSEcCtD
Raltegravir—Hot flush—Doxorubicin—muscle cancer	0.000834	0.00239	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000831	0.00238	CcSEcCtD
Raltegravir—Increased appetite—Doxorubicin—muscle cancer	0.00083	0.00238	CcSEcCtD
Raltegravir—Menopausal symptoms—Doxorubicin—muscle cancer	0.000827	0.00237	CcSEcCtD
Raltegravir—Insomnia—Vincristine—muscle cancer	0.000825	0.00237	CcSEcCtD
Raltegravir—Renal impairment—Doxorubicin—muscle cancer	0.00082	0.00235	CcSEcCtD
Raltegravir—Paraesthesia—Vincristine—muscle cancer	0.000819	0.00235	CcSEcCtD
Raltegravir—Malaise—Etoposide—muscle cancer	0.000817	0.00234	CcSEcCtD
Raltegravir—Breast disorder—Methotrexate—muscle cancer	0.000814	0.00233	CcSEcCtD
Raltegravir—Vertigo—Etoposide—muscle cancer	0.000814	0.00233	CcSEcCtD
Raltegravir—Abdominal pain—Dactinomycin—muscle cancer	0.000807	0.00232	CcSEcCtD
Raltegravir—Body temperature increased—Dactinomycin—muscle cancer	0.000807	0.00232	CcSEcCtD
Raltegravir—Lethargy—Doxorubicin—muscle cancer	0.000796	0.00228	CcSEcCtD
Raltegravir—Decreased appetite—Vincristine—muscle cancer	0.000793	0.00227	CcSEcCtD
Raltegravir—Cough—Etoposide—muscle cancer	0.00079	0.00227	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Vincristine—muscle cancer	0.000788	0.00226	CcSEcCtD
Raltegravir—Fatigue—Vincristine—muscle cancer	0.000787	0.00226	CcSEcCtD
Raltegravir—Hypertension—Etoposide—muscle cancer	0.000782	0.00224	CcSEcCtD
Raltegravir—Constipation—Vincristine—muscle cancer	0.00078	0.00224	CcSEcCtD
Raltegravir—Pain—Vincristine—muscle cancer	0.00078	0.00224	CcSEcCtD
Raltegravir—Pain in extremity—Doxorubicin—muscle cancer	0.00078	0.00224	CcSEcCtD
Raltegravir—Chest pain—Etoposide—muscle cancer	0.000771	0.00221	CcSEcCtD
Raltegravir—Eosinophilia—Methotrexate—muscle cancer	0.000771	0.00221	CcSEcCtD
Raltegravir—Affect lability—Doxorubicin—muscle cancer	0.000768	0.0022	CcSEcCtD
Raltegravir—Migraine—Doxorubicin—muscle cancer	0.000768	0.0022	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000766	0.0022	CcSEcCtD
Raltegravir—Discomfort—Etoposide—muscle cancer	0.000762	0.00218	CcSEcCtD
Raltegravir—Face oedema—Doxorubicin—muscle cancer	0.000753	0.00216	CcSEcCtD
Raltegravir—Hypersensitivity—Dactinomycin—muscle cancer	0.000752	0.00216	CcSEcCtD
Raltegravir—Abdominal discomfort—Methotrexate—muscle cancer	0.000746	0.00214	CcSEcCtD
Raltegravir—Gastrointestinal pain—Vincristine—muscle cancer	0.000746	0.00214	CcSEcCtD
Raltegravir—Confusional state—Etoposide—muscle cancer	0.000745	0.00214	CcSEcCtD
Raltegravir—Mood swings—Doxorubicin—muscle cancer	0.000739	0.00212	CcSEcCtD
Raltegravir—Infection—Etoposide—muscle cancer	0.000734	0.00211	CcSEcCtD
Raltegravir—Asthenia—Dactinomycin—muscle cancer	0.000733	0.0021	CcSEcCtD
Raltegravir—Blood creatinine increased—Doxorubicin—muscle cancer	0.000731	0.0021	CcSEcCtD
Raltegravir—Neutropenia—Methotrexate—muscle cancer	0.000728	0.00209	CcSEcCtD
Raltegravir—Thrombocytopenia—Etoposide—muscle cancer	0.000724	0.00208	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000724	0.00208	CcSEcCtD
Raltegravir—Abdominal pain—Vincristine—muscle cancer	0.000721	0.00207	CcSEcCtD
Raltegravir—Body temperature increased—Vincristine—muscle cancer	0.000721	0.00207	CcSEcCtD
Raltegravir—Skin disorder—Etoposide—muscle cancer	0.000718	0.00206	CcSEcCtD
Raltegravir—Erectile dysfunction—Methotrexate—muscle cancer	0.000717	0.00206	CcSEcCtD
Raltegravir—Dry skin—Doxorubicin—muscle cancer	0.000715	0.00205	CcSEcCtD
Raltegravir—Hyperhidrosis—Etoposide—muscle cancer	0.000715	0.00205	CcSEcCtD
Raltegravir—Abdominal pain upper—Doxorubicin—muscle cancer	0.000712	0.00204	CcSEcCtD
Raltegravir—Breast disorder—Doxorubicin—muscle cancer	0.000705	0.00202	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000702	0.00201	CcSEcCtD
Raltegravir—Diarrhoea—Dactinomycin—muscle cancer	0.000699	0.002	CcSEcCtD
Raltegravir—Nasopharyngitis—Doxorubicin—muscle cancer	0.000697	0.002	CcSEcCtD
Raltegravir—Infestation NOS—Methotrexate—muscle cancer	0.000694	0.00199	CcSEcCtD
Raltegravir—Infestation—Methotrexate—muscle cancer	0.000694	0.00199	CcSEcCtD
Raltegravir—Depression—Methotrexate—muscle cancer	0.000692	0.00199	CcSEcCtD
Raltegravir—Gastritis—Doxorubicin—muscle cancer	0.00069	0.00198	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000688	0.00197	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000688	0.00197	CcSEcCtD
Raltegravir—Renal failure—Methotrexate—muscle cancer	0.000682	0.00196	CcSEcCtD
Raltegravir—Abdominal distension—Doxorubicin—muscle cancer	0.000679	0.00195	CcSEcCtD
Raltegravir—Influenza—Doxorubicin—muscle cancer	0.000674	0.00193	CcSEcCtD
Raltegravir—Hypersensitivity—Vincristine—muscle cancer	0.000672	0.00193	CcSEcCtD
Raltegravir—Eosinophilia—Doxorubicin—muscle cancer	0.000667	0.00191	CcSEcCtD
Raltegravir—Paraesthesia—Etoposide—muscle cancer	0.000664	0.0019	CcSEcCtD
Raltegravir—UGT1A1—renal system—muscle cancer	0.000664	0.123	CbGeAlD
Raltegravir—Haematuria—Methotrexate—muscle cancer	0.000662	0.0019	CcSEcCtD
Raltegravir—Somnolence—Etoposide—muscle cancer	0.000657	0.00188	CcSEcCtD
Raltegravir—Hepatobiliary disease—Methotrexate—muscle cancer	0.000657	0.00188	CcSEcCtD
Raltegravir—Epistaxis—Methotrexate—muscle cancer	0.000655	0.00188	CcSEcCtD
Raltegravir—Asthenia—Vincristine—muscle cancer	0.000655	0.00188	CcSEcCtD
Raltegravir—Vomiting—Dactinomycin—muscle cancer	0.000649	0.00186	CcSEcCtD
Raltegravir—Bronchitis—Doxorubicin—muscle cancer	0.000648	0.00186	CcSEcCtD
Raltegravir—Rash—Dactinomycin—muscle cancer	0.000644	0.00185	CcSEcCtD
Raltegravir—Decreased appetite—Etoposide—muscle cancer	0.000643	0.00184	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Etoposide—muscle cancer	0.000638	0.00183	CcSEcCtD
Raltegravir—Fatigue—Etoposide—muscle cancer	0.000637	0.00183	CcSEcCtD
Raltegravir—Pain—Etoposide—muscle cancer	0.000632	0.00181	CcSEcCtD
Raltegravir—Constipation—Etoposide—muscle cancer	0.000632	0.00181	CcSEcCtD
Raltegravir—Neutropenia—Doxorubicin—muscle cancer	0.00063	0.00181	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000627	0.0018	CcSEcCtD
Raltegravir—Diarrhoea—Vincristine—muscle cancer	0.000624	0.00179	CcSEcCtD
Raltegravir—Hepatitis—Methotrexate—muscle cancer	0.000623	0.00179	CcSEcCtD
Raltegravir—Urinary tract disorder—Methotrexate—muscle cancer	0.000615	0.00177	CcSEcCtD
Raltegravir—Weight increased—Doxorubicin—muscle cancer	0.000614	0.00176	CcSEcCtD
Raltegravir—Urethral disorder—Methotrexate—muscle cancer	0.000611	0.00175	CcSEcCtD
Raltegravir—Weight decreased—Doxorubicin—muscle cancer	0.00061	0.00175	CcSEcCtD
Raltegravir—Feeling abnormal—Etoposide—muscle cancer	0.000609	0.00175	CcSEcCtD
Raltegravir—Hyperglycaemia—Doxorubicin—muscle cancer	0.000608	0.00174	CcSEcCtD
Raltegravir—Nausea—Dactinomycin—muscle cancer	0.000607	0.00174	CcSEcCtD
Raltegravir—Gastrointestinal pain—Etoposide—muscle cancer	0.000604	0.00173	CcSEcCtD
Raltegravir—Dizziness—Vincristine—muscle cancer	0.000603	0.00173	CcSEcCtD
Raltegravir—Infestation—Doxorubicin—muscle cancer	0.000601	0.00172	CcSEcCtD
Raltegravir—Infestation NOS—Doxorubicin—muscle cancer	0.000601	0.00172	CcSEcCtD
Raltegravir—Visual impairment—Methotrexate—muscle cancer	0.000601	0.00172	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000596	0.00171	CcSEcCtD
Raltegravir—Renal failure—Doxorubicin—muscle cancer	0.000591	0.00169	CcSEcCtD
Raltegravir—Erythema multiforme—Methotrexate—muscle cancer	0.000589	0.00169	CcSEcCtD
Raltegravir—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000589	0.00169	CcSEcCtD
Raltegravir—Urticaria—Etoposide—muscle cancer	0.000587	0.00168	CcSEcCtD
Raltegravir—Abdominal pain—Etoposide—muscle cancer	0.000584	0.00168	CcSEcCtD
Raltegravir—Body temperature increased—Etoposide—muscle cancer	0.000584	0.00168	CcSEcCtD
Raltegravir—Eye disorder—Methotrexate—muscle cancer	0.000582	0.00167	CcSEcCtD
Raltegravir—Tinnitus—Methotrexate—muscle cancer	0.000581	0.00167	CcSEcCtD
Raltegravir—Vomiting—Vincristine—muscle cancer	0.00058	0.00166	CcSEcCtD
Raltegravir—Cardiac disorder—Methotrexate—muscle cancer	0.000578	0.00166	CcSEcCtD
Raltegravir—Rash—Vincristine—muscle cancer	0.000575	0.00165	CcSEcCtD
Raltegravir—Dermatitis—Vincristine—muscle cancer	0.000575	0.00165	CcSEcCtD
Raltegravir—Haematuria—Doxorubicin—muscle cancer	0.000573	0.00164	CcSEcCtD
Raltegravir—Headache—Vincristine—muscle cancer	0.000572	0.00164	CcSEcCtD
Raltegravir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000568	0.00163	CcSEcCtD
Raltegravir—Epistaxis—Doxorubicin—muscle cancer	0.000567	0.00163	CcSEcCtD
Raltegravir—Angiopathy—Methotrexate—muscle cancer	0.000565	0.00162	CcSEcCtD
Raltegravir—Immune system disorder—Methotrexate—muscle cancer	0.000563	0.00161	CcSEcCtD
Raltegravir—Mediastinal disorder—Methotrexate—muscle cancer	0.000562	0.00161	CcSEcCtD
Raltegravir—Chills—Methotrexate—muscle cancer	0.000559	0.0016	CcSEcCtD
Raltegravir—Alopecia—Methotrexate—muscle cancer	0.000551	0.00158	CcSEcCtD
Raltegravir—Mental disorder—Methotrexate—muscle cancer	0.000546	0.00157	CcSEcCtD
Raltegravir—Hypersensitivity—Etoposide—muscle cancer	0.000545	0.00156	CcSEcCtD
Raltegravir—Malnutrition—Methotrexate—muscle cancer	0.000542	0.00156	CcSEcCtD
Raltegravir—Erythema—Methotrexate—muscle cancer	0.000542	0.00156	CcSEcCtD
Raltegravir—Nausea—Vincristine—muscle cancer	0.000542	0.00155	CcSEcCtD
Raltegravir—Hepatitis—Doxorubicin—muscle cancer	0.00054	0.00155	CcSEcCtD
Raltegravir—Hypoaesthesia—Doxorubicin—muscle cancer	0.000537	0.00154	CcSEcCtD
Raltegravir—Urinary tract disorder—Doxorubicin—muscle cancer	0.000533	0.00153	CcSEcCtD
Raltegravir—Oedema peripheral—Doxorubicin—muscle cancer	0.000532	0.00152	CcSEcCtD
Raltegravir—Dysgeusia—Methotrexate—muscle cancer	0.000531	0.00152	CcSEcCtD
Raltegravir—Asthenia—Etoposide—muscle cancer	0.00053	0.00152	CcSEcCtD
Raltegravir—Connective tissue disorder—Doxorubicin—muscle cancer	0.00053	0.00152	CcSEcCtD
Raltegravir—Urethral disorder—Doxorubicin—muscle cancer	0.000529	0.00152	CcSEcCtD
Raltegravir—Back pain—Methotrexate—muscle cancer	0.000525	0.00151	CcSEcCtD
Raltegravir—Pruritus—Etoposide—muscle cancer	0.000523	0.0015	CcSEcCtD
Raltegravir—Visual impairment—Doxorubicin—muscle cancer	0.00052	0.00149	CcSEcCtD
Raltegravir—Erythema multiforme—Doxorubicin—muscle cancer	0.00051	0.00146	CcSEcCtD
Raltegravir—Diarrhoea—Etoposide—muscle cancer	0.000506	0.00145	CcSEcCtD
Raltegravir—Eye disorder—Doxorubicin—muscle cancer	0.000504	0.00145	CcSEcCtD
Raltegravir—Ill-defined disorder—Methotrexate—muscle cancer	0.000503	0.00144	CcSEcCtD
Raltegravir—Tinnitus—Doxorubicin—muscle cancer	0.000503	0.00144	CcSEcCtD
Raltegravir—Anaemia—Methotrexate—muscle cancer	0.000501	0.00144	CcSEcCtD
Raltegravir—Cardiac disorder—Doxorubicin—muscle cancer	0.000501	0.00144	CcSEcCtD
Raltegravir—Angiopathy—Doxorubicin—muscle cancer	0.00049	0.0014	CcSEcCtD
Raltegravir—Malaise—Methotrexate—muscle cancer	0.000489	0.0014	CcSEcCtD
Raltegravir—Dizziness—Etoposide—muscle cancer	0.000489	0.0014	CcSEcCtD
Raltegravir—Immune system disorder—Doxorubicin—muscle cancer	0.000487	0.0014	CcSEcCtD
Raltegravir—Vertigo—Methotrexate—muscle cancer	0.000487	0.0014	CcSEcCtD
Raltegravir—Mediastinal disorder—Doxorubicin—muscle cancer	0.000486	0.00139	CcSEcCtD
Raltegravir—Chills—Doxorubicin—muscle cancer	0.000484	0.00139	CcSEcCtD
Raltegravir—Alopecia—Doxorubicin—muscle cancer	0.000477	0.00137	CcSEcCtD
Raltegravir—Cough—Methotrexate—muscle cancer	0.000473	0.00136	CcSEcCtD
Raltegravir—Mental disorder—Doxorubicin—muscle cancer	0.000473	0.00136	CcSEcCtD
Raltegravir—Vomiting—Etoposide—muscle cancer	0.00047	0.00135	CcSEcCtD
Raltegravir—Malnutrition—Doxorubicin—muscle cancer	0.00047	0.00135	CcSEcCtD
Raltegravir—Erythema—Doxorubicin—muscle cancer	0.00047	0.00135	CcSEcCtD
Raltegravir—Rash—Etoposide—muscle cancer	0.000466	0.00134	CcSEcCtD
Raltegravir—Dermatitis—Etoposide—muscle cancer	0.000466	0.00134	CcSEcCtD
Raltegravir—Headache—Etoposide—muscle cancer	0.000463	0.00133	CcSEcCtD
Raltegravir—Flatulence—Doxorubicin—muscle cancer	0.000463	0.00133	CcSEcCtD
Raltegravir—Myalgia—Methotrexate—muscle cancer	0.000462	0.00132	CcSEcCtD
Raltegravir—Arthralgia—Methotrexate—muscle cancer	0.000462	0.00132	CcSEcCtD
Raltegravir—Chest pain—Methotrexate—muscle cancer	0.000462	0.00132	CcSEcCtD
Raltegravir—Dysgeusia—Doxorubicin—muscle cancer	0.00046	0.00132	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000459	0.00132	CcSEcCtD
Raltegravir—Discomfort—Methotrexate—muscle cancer	0.000456	0.00131	CcSEcCtD
Raltegravir—Nervousness—Doxorubicin—muscle cancer	0.000456	0.00131	CcSEcCtD
Raltegravir—Back pain—Doxorubicin—muscle cancer	0.000454	0.0013	CcSEcCtD
Raltegravir—Confusional state—Methotrexate—muscle cancer	0.000446	0.00128	CcSEcCtD
Raltegravir—Infection—Methotrexate—muscle cancer	0.00044	0.00126	CcSEcCtD
Raltegravir—Nausea—Etoposide—muscle cancer	0.000439	0.00126	CcSEcCtD
Raltegravir—Ill-defined disorder—Doxorubicin—muscle cancer	0.000436	0.00125	CcSEcCtD
Raltegravir—Nervous system disorder—Methotrexate—muscle cancer	0.000434	0.00125	CcSEcCtD
Raltegravir—Anaemia—Doxorubicin—muscle cancer	0.000434	0.00125	CcSEcCtD
Raltegravir—Thrombocytopenia—Methotrexate—muscle cancer	0.000433	0.00124	CcSEcCtD
Raltegravir—Agitation—Doxorubicin—muscle cancer	0.000432	0.00124	CcSEcCtD
Raltegravir—Skin disorder—Methotrexate—muscle cancer	0.00043	0.00123	CcSEcCtD
Raltegravir—Hyperhidrosis—Methotrexate—muscle cancer	0.000428	0.00123	CcSEcCtD
Raltegravir—Malaise—Doxorubicin—muscle cancer	0.000424	0.00121	CcSEcCtD
Raltegravir—Vertigo—Doxorubicin—muscle cancer	0.000422	0.00121	CcSEcCtD
Raltegravir—Palpitations—Doxorubicin—muscle cancer	0.000415	0.00119	CcSEcCtD
Raltegravir—Cough—Doxorubicin—muscle cancer	0.00041	0.00118	CcSEcCtD
Raltegravir—Hypertension—Doxorubicin—muscle cancer	0.000406	0.00116	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000403	0.00116	CcSEcCtD
Raltegravir—Insomnia—Methotrexate—muscle cancer	0.0004	0.00115	CcSEcCtD
Raltegravir—Arthralgia—Doxorubicin—muscle cancer	0.0004	0.00115	CcSEcCtD
Raltegravir—Myalgia—Doxorubicin—muscle cancer	0.0004	0.00115	CcSEcCtD
Raltegravir—Chest pain—Doxorubicin—muscle cancer	0.0004	0.00115	CcSEcCtD
Raltegravir—Anxiety—Doxorubicin—muscle cancer	0.000399	0.00114	CcSEcCtD
Raltegravir—Paraesthesia—Methotrexate—muscle cancer	0.000398	0.00114	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000397	0.00114	CcSEcCtD
Raltegravir—Discomfort—Doxorubicin—muscle cancer	0.000395	0.00113	CcSEcCtD
Raltegravir—Somnolence—Methotrexate—muscle cancer	0.000394	0.00113	CcSEcCtD
Raltegravir—Dry mouth—Doxorubicin—muscle cancer	0.000391	0.00112	CcSEcCtD
Raltegravir—Dyspepsia—Methotrexate—muscle cancer	0.00039	0.00112	CcSEcCtD
Raltegravir—Confusional state—Doxorubicin—muscle cancer	0.000387	0.00111	CcSEcCtD
Raltegravir—Decreased appetite—Methotrexate—muscle cancer	0.000385	0.0011	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000382	0.0011	CcSEcCtD
Raltegravir—Fatigue—Methotrexate—muscle cancer	0.000382	0.00109	CcSEcCtD
Raltegravir—Infection—Doxorubicin—muscle cancer	0.000381	0.00109	CcSEcCtD
Raltegravir—Pain—Methotrexate—muscle cancer	0.000379	0.00109	CcSEcCtD
Raltegravir—Nervous system disorder—Doxorubicin—muscle cancer	0.000376	0.00108	CcSEcCtD
Raltegravir—Thrombocytopenia—Doxorubicin—muscle cancer	0.000375	0.00108	CcSEcCtD
Raltegravir—Skin disorder—Doxorubicin—muscle cancer	0.000372	0.00107	CcSEcCtD
Raltegravir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000371	0.00106	CcSEcCtD
Raltegravir—Feeling abnormal—Methotrexate—muscle cancer	0.000365	0.00105	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000362	0.00104	CcSEcCtD
Raltegravir—Urticaria—Methotrexate—muscle cancer	0.000352	0.00101	CcSEcCtD
Raltegravir—Body temperature increased—Methotrexate—muscle cancer	0.00035	0.001	CcSEcCtD
Raltegravir—Abdominal pain—Methotrexate—muscle cancer	0.00035	0.001	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000349	0.001	CcSEcCtD
Raltegravir—Insomnia—Doxorubicin—muscle cancer	0.000347	0.000994	CcSEcCtD
Raltegravir—Paraesthesia—Doxorubicin—muscle cancer	0.000344	0.000987	CcSEcCtD
Raltegravir—Somnolence—Doxorubicin—muscle cancer	0.000341	0.000978	CcSEcCtD
Raltegravir—Dyspepsia—Doxorubicin—muscle cancer	0.000337	0.000968	CcSEcCtD
Raltegravir—Decreased appetite—Doxorubicin—muscle cancer	0.000333	0.000956	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000331	0.000949	CcSEcCtD
Raltegravir—Fatigue—Doxorubicin—muscle cancer	0.000331	0.000948	CcSEcCtD
Raltegravir—Pain—Doxorubicin—muscle cancer	0.000328	0.00094	CcSEcCtD
Raltegravir—Constipation—Doxorubicin—muscle cancer	0.000328	0.00094	CcSEcCtD
Raltegravir—Hypersensitivity—Methotrexate—muscle cancer	0.000326	0.000936	CcSEcCtD
Raltegravir—Asthenia—Methotrexate—muscle cancer	0.000318	0.000911	CcSEcCtD
Raltegravir—Feeling abnormal—Doxorubicin—muscle cancer	0.000316	0.000906	CcSEcCtD
Raltegravir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000313	0.000899	CcSEcCtD
Raltegravir—Pruritus—Methotrexate—muscle cancer	0.000313	0.000898	CcSEcCtD
Raltegravir—Urticaria—Doxorubicin—muscle cancer	0.000305	0.000874	CcSEcCtD
Raltegravir—Abdominal pain—Doxorubicin—muscle cancer	0.000303	0.000869	CcSEcCtD
Raltegravir—Body temperature increased—Doxorubicin—muscle cancer	0.000303	0.000869	CcSEcCtD
Raltegravir—Diarrhoea—Methotrexate—muscle cancer	0.000303	0.000869	CcSEcCtD
Raltegravir—Dizziness—Methotrexate—muscle cancer	0.000293	0.00084	CcSEcCtD
Raltegravir—Hypersensitivity—Doxorubicin—muscle cancer	0.000282	0.00081	CcSEcCtD
Raltegravir—Vomiting—Methotrexate—muscle cancer	0.000281	0.000807	CcSEcCtD
Raltegravir—Rash—Methotrexate—muscle cancer	0.000279	0.000801	CcSEcCtD
Raltegravir—Dermatitis—Methotrexate—muscle cancer	0.000279	0.0008	CcSEcCtD
Raltegravir—Headache—Methotrexate—muscle cancer	0.000277	0.000796	CcSEcCtD
Raltegravir—Asthenia—Doxorubicin—muscle cancer	0.000275	0.000789	CcSEcCtD
Raltegravir—Pruritus—Doxorubicin—muscle cancer	0.000271	0.000778	CcSEcCtD
Raltegravir—Nausea—Methotrexate—muscle cancer	0.000263	0.000754	CcSEcCtD
Raltegravir—Diarrhoea—Doxorubicin—muscle cancer	0.000262	0.000752	CcSEcCtD
Raltegravir—Dizziness—Doxorubicin—muscle cancer	0.000254	0.000727	CcSEcCtD
Raltegravir—Vomiting—Doxorubicin—muscle cancer	0.000244	0.000699	CcSEcCtD
Raltegravir—Rash—Doxorubicin—muscle cancer	0.000242	0.000693	CcSEcCtD
Raltegravir—Dermatitis—Doxorubicin—muscle cancer	0.000241	0.000693	CcSEcCtD
Raltegravir—Headache—Doxorubicin—muscle cancer	0.00024	0.000689	CcSEcCtD
Raltegravir—Nausea—Doxorubicin—muscle cancer	0.000228	0.000653	CcSEcCtD
